News Related to CARsgen Therapeutics

Related coverage linked through entity extraction aliases.

CAR T-Cell Therapy Market Expands with AI Integration and Pipeline Growth

Feb 27, 2026

CAR T-cell therapy market advances with AI-driven manufacturing improvements and over 250 companies developing 500+ drug candidates, including breakthrough solid tumor treatments and GPC3-targeted therapies for hepatocellular carcinoma.

Monoclonal Antibody Pipeline and Market Reports Released for 2026

Feb 16, 2026

Three comprehensive reports examine the monoclonal antibody landscape, covering CD47-targeted immunotherapy pipelines, competitive analysis of 180+ companies developing mAb therapeutics, and recombinant antibody market forecasts through 2033.